Literature DB >> 10830800

Management of alveolar cleft bone grafting--state of the art.

B L Eppley1, A M Sadove.   

Abstract

Bone grafting of the alveolus is an essential step in the reconstruction of the orofacial cleft deformity. Secondary grafting with iliac marrow consistently produces trabecular bone to unify the maxilla and provide odontogenic support. It requires preoperative maxillary alignment, well designed mucoperiosteal flaps, and good oral hygiene to be optimally successful. Its high success rate currently makes it the preferred approach at most centers. Primary grafting with rib results in a unified maxilla, eliminates the oronasal fistula, and does not adversely affect midfacial growth. It assists in preventing maxillary segmental collapse, particularly in the bilateral cleft patient. Whether it can produce enough alveolar bone to support long-term odontogenic needs awaits further clinical documentation in the limited numbers of centers that routinely perform this procedure.

Entities:  

Mesh:

Year:  2000        PMID: 10830800     DOI: 10.1597/1545-1569_2000_037_0229_moacbg_2.3.co_2

Source DB:  PubMed          Journal:  Cleft Palate Craniofac J        ISSN: 1055-6656


  10 in total

1.  Development of a multilayered palate substitute in rabbits: a histochemical ex vivo and in vivo analysis.

Authors:  M A Martín-Piedra; M Alaminos; R Fernández-Valadés-Gámez; A España-López; E Liceras-Liceras; I Sánchez-Montesinos; A Martínez-Plaza; M C Sánchez-Quevedo; R Fernández-Valadés; I Garzón
Journal:  Histochem Cell Biol       Date:  2016-09-06       Impact factor: 4.304

2.  * Tissue Engineering Strategies to Improve Osteogenesis in the Juvenile Swine Alveolar Cleft Model.

Authors:  Montserrat Caballero; Donna C Jones; Zhengyuan Shan; Sajjad Soleimani; John A van Aalst
Journal:  Tissue Eng Part C Methods       Date:  2017-08-31       Impact factor: 3.056

3.  Cone-beam computed tomographic comparison of chin symphysis bone particles and allograft versus iliac crest bone graft alone for reconstruction of alveolar bone defects in cleft patients.

Authors:  Bijan Movahedian Attar; Parisa Soltani; Davood Davari; Mojdeh Mehdizadeh
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2022-04-30

4.  Evaluation of morbidity associated with iliac crest harvest for alveolar cleft bone grafting.

Authors:  Sainath Matsa; Senthil Murugan; Kamal Kannadasan
Journal:  J Maxillofac Oral Surg       Date:  2011-06-09

Review 5.  Alveolar Bone Grafting in Cleft Patients from Bone Defect to Dental Implants.

Authors:  Marko Vuletić; Predrag Knežević; Dražen Jokić; Jerko Rebić; Domagoj Žabarović; Darko Macan
Journal:  Acta Stomatol Croat       Date:  2014-12

6.  Local vs. systemic administration of bisphosphonates in rat cleft bone graft: A comparative study.

Authors:  Christine Hong; Alison Quach; Lawrence Lin; Jeffrey Olson; Taewoo Kwon; Olga Bezouglaia; Jaime Tran; Michael Hoang; Kimberly Bui; Reuben H Kim; Sotirios Tetradis
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

7.  Deciduous Dental Pulp Stem Cells for Maxillary Alveolar Reconstruction in Cleft Lip and Palate Patients.

Authors:  Daniela Y S Tanikawa; Carla C G Pinheiro; Maria Cristina A Almeida; Claudia R G C M Oliveira; Renata de Almeida Coudry; Diógenes Laercio Rocha; Daniela Franco Bueno
Journal:  Stem Cells Int       Date:  2020-03-12       Impact factor: 5.443

8.  An innovative approach in the management of alveolar clefts with bone graft harvest from maxillary tuberosity and mandibular wisdom molar odontectomy sites: A case report.

Authors:  Symon Guthua; Peter M Ng'ang'a; Krishan Sarna; Martin Kamau
Journal:  Clin Case Rep       Date:  2021-12-26

9.  Alveolar Bone Grafting and Fistula Closure.

Authors:  Alexandra Junn; Jacob Dinis; Xiaona Lu; Joseph Lopez; Derek Steinbacher
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-04-29

10.  Low intensity pulsed ultrasound therapy: A potential adjuvant treatment for osteonecrosis of alveolar bone grafting.

Authors:  Qi Chen; Bing Shi; Qian Zheng
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.